Abbvie Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Abbvie's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Abbvie in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
136.76138.11139.46
Details
Intrinsic
Valuation
LowReal ValueHigh
122.81124.16151.84
Details
Naive
Forecast
LowNext ValueHigh
136.15137.50138.86
Details
13 Analysts
Consensus
LowTarget PriceHigh
118.00143.42172.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Abbvie. Your research has to be compared to or analyzed against Abbvie's peers to derive any actionable benefits. When done correctly, Abbvie's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Abbvie Inc.

Abbvie Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Abbvie and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Abbvie and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Abbvie Inc does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Abbvie Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Abbvie stock performing well and Abbvie company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Abbvie's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TRV 1.19 (0.10)  0.00 (0.17)  0.00 (0.06)  0.00  2.17 (2.33)  9.03 
JPM 1.46 (0.05)  0.00 (0.06)  0.00 (0.0288)  0.00  3.31 (2.51)  10.79 
PFE 1.29  0.04  0.02  0.04  1.67  0.0261 (1.25)  2.93 (2.43)  7.74 
DD 1.66 (0.13)  0.00 (0.12)  0.00 (0.06)  0.00  3.56 (3.83)  9.52 
CAT 1.90 (0.16)  0.00 (0.15)  0.00 (0.07)  0.00  4.18 (4.35)  11.37 
MMM 1.19  0.02  0.02  0.02  1.55  0.0167 (1.21)  3.21 (2.24)  8.68 
IBM 1.20  0.03  0.02  0.04  1.80  0.0228 (1.13)  2.10 (2.48)  8.93 

Cross Equities Net Income Analysis

Compare Abbvie Inc and related stocks such as The Travelers Companies, JP Morgan Chase, Pfizer Inc, Dupont Denemours, Caterpillar, 3M Company, and International Business Net Income Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
TRV3.2 B1.4 B2.5 B3.7 B3.7 B3.4 BB2.1 B2.5 B2.6 B2.7 B3.7 B3.1 B
JPM17.6 B17.6 B19.9 B16.6 B20.1 B22.7 B22.8 B22.6 B30.7 B34.6 B27.4 B46.5 B39.3 B
PFE8.3 B10 B14.6 B22 B9.1 BB7.2 B21.3 B11.2 B16.3 B9.6 B22 B23.7 B
DD2.7 B2.7 B1.2 B4.8 B3.8 B7.7 B4.3 B1.2 B3.8 B498 M(3 B)6.5 BB
CAT4.9 B4.9 B5.7 B3.8 B2.5 B2.5 B(67 M)754 M6.1 B6.1 BB6.5 B5.6 B
MMM4.3 B4.3 B4.4 B4.7 BB4.8 BB4.9 B5.3 B4.5 B5.4 B5.9 BB
IBM15.9 B15.9 B16.6 B16.5 B12 B13.2 B11.9 B5.8 B8.7 B9.4 B5.6 B5.7 B7.7 B

Abbvie Inc and related stocks such as The Travelers Companies, JP Morgan Chase, Pfizer Inc, Dupont Denemours, Caterpillar, 3M Company, and International Business Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Abbvie Inc financial statement analysis. It represents the amount of money remaining after all of Abbvie Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Abbvie Competitive Analysis

The better you understand Abbvie competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Abbvie's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Abbvie's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ABBVTRVJPMPFEDDCATMMMIBM
 0.63 
 138.04 
Abbvie
 0.80 
 158.96 
Travelers
 3.03 
 115.76 
JP Morgan
 1.18 
 49.27 
Pfizer
 0.53 
 58.88 
Dupont
 0.95 
 185.39 
Caterpillar
 0.48 
 147.41 
3M
 0.64 
 132.48 
International
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Abbvie Competition Performance Charts

Complement your Abbvie position

In addition to having Abbvie in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Manufacturing Thematic Idea Now

Manufacturing
Manufacturing Theme
Companies that provide goods across residential, commercial and industrial construction such as machinery, tools, or lumber production. The Manufacturing theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Manufacturing Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Abbvie Correlation with its peers. Note that the Abbvie Inc information on this page should be used as a complementary analysis to other Abbvie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Abbvie Stock analysis

When running Abbvie Inc price analysis, check to measure Abbvie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbvie is operating at the current time. Most of Abbvie's value examination focuses on studying past and present price action to predict the probability of Abbvie's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbvie's price. Additionally, you may evaluate how the addition of Abbvie to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Is Abbvie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbvie. If investors know Abbvie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbvie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.22
Market Capitalization
244.1 B
Quarterly Revenue Growth YOY
0.045
Return On Assets
0.0863
Return On Equity
0.83
The market value of Abbvie Inc is measured differently than its book value, which is the value of Abbvie that is recorded on the company's balance sheet. Investors also form their own opinion of Abbvie's value that differs from its market value or its book value, called intrinsic value, which is Abbvie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbvie's market value can be influenced by many factors that don't directly affect Abbvie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbvie's value and its price as these two are different measures arrived at by different means. Investors typically determine Abbvie value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbvie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ABBV
 Stock
  

USD 138.04  0.88  0.63%   

Abbvie Inc competes with Travelers Companies, JP Morgan, Pfizer, Dupont Denemours, and Caterpillar; as well as few others. The company conducts business under Healthcare sector and is part of Drug Manufacturers—General industry. Analyzing Abbvie competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Abbvie to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Abbvie competition on your existing holdings. Please continue to Abbvie Correlation with its peers.
  
Abbvie Return on Investment is fairly stable at the moment as compared to the past year. Abbvie reported Return on Investment of 18.75 in 2021. Return on Average Assets is likely to climb to 0.09 in 2022, whereas Return on Sales is likely to drop 0.25 in 2022. Abbvie Assets Non Current are fairly stable at the moment as compared to the past year. Abbvie reported Assets Non Current of 118.6 Billion in 2021. Goodwill and Intangible Assets is likely to climb to about 116.9 B in 2022, whereas Current Assets are likely to drop slightly above 26.7 B in 2022.